|
|
|
41
|
A3612
|
ARCALION 200MG TAB (SER) SULBUTIAMI (C)
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.2232
|
TAB
|
0
|
BOX
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
42
|
A3612
|
ARCALION 200MG TAB (SER) SULBUTIAMI
|
SULBUTIAMINE
|
ARCALION
|
20'S
|
C
|
24.46
|
1.22
|
TAB
|
0
|
BLIS
|
SER
|
LES LABORATOIRES SERVIER
|
COL
|
AVENTA BARBADOS
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
ORAL
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A3613
|
SULBUTIAMINE 200MG TAB (KWA/ATB)
|
SULBUTIAMINE
|
SULBUTIAMINE
|
20'S
|
C
|
12.23
|
0.61
|
TABLET
|
0
|
TAB
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
|
40
|
A3711
|
TRUSOPT 2% EYE DR (MSD/STO) DORZOLAMIDE
|
DORZOLAMIDE
|
TRUSOPT
|
5ML
|
C
|
28.54
|
28.54
|
EYE DROP
|
0
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
A3711
|
TRUSOPT 2% EYE DR (MSD/STO) DORZOLAMIDE (C)
|
DORZOLAMIDE
|
TRUSOPT
|
5ML
|
C
|
28.54
|
28.54
|
EYE DROP
|
0
|
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2022-12-31
|
Del
|
OPHTHALMIC
|
0
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-12-31
|
|
|
|
40
|
A3711
|
TRUSOPT 2% EYE DR (MSD/STO) DORZOLAMIDE (C)
|
DORZOLAMIDE
|
TRUSOPT
|
5ML
|
C
|
28.54
|
28.54
|
EYE DROP
|
|
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-04
|
2022-12-31
|
Delete from contract
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-12-31
|
|
|
|
40
|
A3714
|
GLAUCOTENSIL D 2% EYE DR (LPO/COL) DORZOLAMID
|
DORZOLAMIDE
|
GLAUCOTENSIL D
|
5ML
|
A
|
14.95
|
14.95
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
A3714
|
GLAUCOTENSIL D 2% EYE DR (LPO) DORZOLAMI (C)
|
DORZOLAMIDE
|
GLAUCOTENSIL D
|
5ML
|
C
|
16.45
|
16.4459
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
A3714
|
GLAUCOTENSIL D 2% EYE DR (LPO) DORZOLAMI
|
DORZOLAMIDE
|
GLAUCOTENSIL D
|
5ML
|
B
|
20.39
|
20.39
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
40
|
A371E
|
BRIZOTEN 1% EYE DR (LPO/COL) BRINZOLAMIDE
|
BRINZOLAMIDE
|
BRIZOTEN
|
5ML
|
A
|
19.03
|
19.03
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
42
|
A371E
|
BRIZOTEN 1% EYE DR (LPO) BRINZOLAMIDE
|
BRINZOLAMIDE
|
BRIZOTEN
|
5ML
|
C
|
24.46
|
24.46
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
40
|
A371H
|
DORZOL 2% EYE DR (CIR/AHI)
|
DORZOLAMIDE
|
DORZOL
|
5ML
|
A
|
12.12
|
12.12
|
EYE DROP
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
A371H
|
DORZOL 2% EYE DR (CIR)
|
DORZOLAMIDE
|
DORZOL
|
5ML
|
A
|
13.73
|
13.7275
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
41
|
A371R
|
AZOPT 1% EYE DR (NVS) BRINZOLAMIDE
|
BRINZOLAMIDE
|
AZOPT
|
10ML
|
A
|
29.22
|
29.222
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2024-06-17
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-05-06
|
|
|
|
41
|
A371T
|
ENDOR 2% EYE DR (SYP) DORZOLAMIDE
|
DORZOLAMIDE
|
ENDOR
|
5ML
|
A
|
12.69
|
12.6946
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
42
|
A371T
|
ENDOR 2% EYE DR (SYP) DORZOLAMIDE
|
DORZOLAMIDE
|
ENDOR
|
5ML
|
A
|
10.95
|
10.95
|
BOTT
|
1
|
BOTT
|
SYP
|
SYAASH PHARMACEUTICALS
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
41
|
A371V
|
AZOPT 1% DROPS (NVS) BRINZOLAMIDE
|
BRINZOLAMIDE
|
AZOPT
|
5ML BOTT
|
A
|
14.61
|
14.61
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-05-06
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
2024-05-06
|
|
|
|
42
|
A371V
|
AZOPT 1% EYE DR (NVS) BRINZOLAMIDE
|
BRINZOLAMIDE
|
AZOPT
|
5ML
|
A
|
14.62
|
14.62
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
B
|
402804
|
CARBONIC ANHYDRASE INHIBITORS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
CARBONIC ANHYDRASE INHIBITORS
|
|
|
|
|
41
|
A371W
|
DORZOL 2% EYE DR (CIR)
|
DORZOLAMIDE
|
DORZOL
|
10ML
|
A
|
21.75
|
21.75
|
BOTT
|
1
|
BOTT
|
CIR
|
CIRON PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
524012
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2025-01-10
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
EENT CARBONIC ANHYDRASE INHIBITORS
|
2025-01-10
|
|
|
|
40
|
A3911
|
SERETIDE DISKUS 250MCG | 50MCG INHR (GSK/COL) F
|
FLUTICASONE|SALMETEROL
|
SERETIDE DISKUS
|
60 DOSES
|
C
|
55.45
|
55.45
|
INHALER
|
0
|
INHR
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
B
|
4892
|
RESPIRATORY AGENTS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
ORAL INHALATION
|
0
|
RESPIRATORY TRACT AGENTS
|
|